Literature DB >> 15731503

Neuropeptide S: a new player in the modulation of arousal and anxiety.

Rainer K Reinscheid1, Yan-Ling Xu, Olivier Civelli.   

Abstract

Neuropeptide S (NPS) is a newly identified transmitter that modulates arousal and fear responses. NPS activates an orphan G protein-coupled receptor that is expressed throughout the central nervous system, including brain centers that regulate sleep/wakefulness and anxiety. In contrast, the NPS precursor mRNA is found only in a few discrete nuclei in the brainstem as well as in a few scattered cells in the hypothalamus and amygdala. The most prominent expression of NPS precursor is found in a previously uncharacterized cluster of neurons in the pontine area, located between the noradrenergic locus ceruleus and Barrington's nucleus. Central administration of NPS induces long-lasting arousal and suppresses all stages of sleep. In addition, NPS produces an anxiolytic profile in a variety of behavioral models. The unique pharmacological spectrum of NPS makes it an interesting target for pharmaceutical development. It also enhances our understanding of the neurobiological mechanisms of sleep/wakefulness regulation and the neuronal processing of stress.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731503     DOI: 10.1124/mi5.1.8

Source DB:  PubMed          Journal:  Mol Interv        ISSN: 1534-0384


  15 in total

1.  Centrally administered neuropeptide S activates orexin-containing neurons in the hypothalamus and stimulates feeding in rats.

Authors:  Michio Niimi
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

2.  Increased GABAergic Efficacy of Central Amygdala Projections to Neuropeptide S Neurons in the Brainstem During Fear Memory Retrieval.

Authors:  Kay Jüngling; Maren D Lange; Hanna J Szkudlarek; Jörg Lesting; Frank S Erdmann; Michael Doengi; Sebastian Kügler; Hans-Christian Pape
Journal:  Neuropsychopharmacology       Date:  2015-05-04       Impact factor: 7.853

Review 3.  In search of analgesia: emerging roles of GPCRs in pain.

Authors:  Laura S Stone; Derek C Molliver
Journal:  Mol Interv       Date:  2009-10

4.  Non-synonymous polymorphism in the neuropeptide S precursor gene and sleep apnea.

Authors:  Manuel Sánchez-de-la-Torre; Javier Pierola; Carme Vidal; Antonia Barceló; Mónica de la Peña; Zahid Hussain; Francisco Capote; Joaquín Durán; Alvar G N Agustí; Luis de Lecea; Gerard Torres; Cristina Esquinas; Montserrat Martinez; Ferran Barbé
Journal:  Sleep Breath       Date:  2010-04-21       Impact factor: 2.816

5.  Neuropeptide-S (NPS) receptor genotype modulates basolateral amygdala responsiveness to aversive stimuli.

Authors:  Udo Dannlowski; Harald Kugel; Friederike Franke; Anja Stuhrmann; Christa Hohoff; Peter Zwanzger; Thomas Lenzen; Dominik Grotegerd; Thomas Suslow; Volker Arolt; Walter Heindel; Katharina Domschke
Journal:  Neuropsychopharmacology       Date:  2011-04-27       Impact factor: 7.853

6.  Neuropeptide S attenuates neuropathological, neurochemical and behavioral changes induced by the NMDA receptor antagonist MK-801.

Authors:  Naoe Okamura; Rainer K Reinscheid; Shintaro Ohgake; Masaomi Iyo; Kenji Hashimoto
Journal:  Neuropharmacology       Date:  2009-07-02       Impact factor: 5.250

7.  Antagonism of the neuropeptide S receptor with RTI-118 decreases cocaine self-administration and cocaine-seeking behavior in rats.

Authors:  Christopher D Schmoutz; Yanan Zhang; Scott P Runyon; Nicholas E Goeders
Journal:  Pharmacol Biochem Behav       Date:  2012-09-12       Impact factor: 3.533

8.  Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through corticotropin-releasing factor receptor 1 in mice.

Authors:  Covadonga Pañeda; Salvador Huitron-Resendiz; Laura M Frago; Julie A Chowen; Roberto Picetti; Luis de Lecea; Amanda J Roberts
Journal:  J Neurosci       Date:  2009-04-01       Impact factor: 6.167

9.  Pain catastrophizing: an updated review.

Authors:  Lawrence Leung
Journal:  Indian J Psychol Med       Date:  2012-07

Review 10.  A review on experimental and clinical genetic associations studies on fear conditioning, extinction and cognitive-behavioral treatment.

Authors:  T B Lonsdorf; R Kalisch
Journal:  Transl Psychiatry       Date:  2011-09-20       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.